Published in Eur J Endocrinol on July 21, 2008
The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab (2013) 1.50
US detection of renal and ureteral calculi in patients with suspected renal colic. Crit Ultrasound J (2013) 0.77
How the preoperative ultrasound examination and BFI of the cervical lymph nodes modify the therapeutic treatment in patients with papillary thyroid cancer. BMC Surg (2013) 0.75
Is vascular flow a predictor of malignant thyroid nodules? A meta-analysis. Gland Surg (2016) 0.75
B-flow twinkling sign in preoperative evaluation of cervical lymph nodes in patients with papillary thyroid carcinoma. Int J Endocrinol (2013) 0.75
Dominant factor analysis of B-flow twinkling sign with phantom and simulation data. J Med Ultrason (2001) (2016) 0.75
Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 22.71
Management of a solitary thyroid nodule. N Engl J Med (1993) 7.15
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol (2006) 6.57
Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology (2005) 4.96
Clinical practice. The thyroid nodule. N Engl J Med (2004) 4.84
Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med (1993) 4.09
Thyroid carcinoma. Lancet (2003) 4.08
Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab (2006) 3.50
Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med (1997) 3.44
Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ (1992) 2.99
Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab (2006) 2.31
Color Doppler twinkling artifact in hyperechoic regions. Radiology (1996) 1.97
Thyroid cancer: is the incidence still increasing? Ann Surg Oncol (2004) 1.82
Thyroid carcinoma in single cold nodules and in cold nodules of multinodular goiters. Endocr Pract (2001) 1.64
The epidemiology of thyroid carcinoma. Crit Rev Oncog (1993) 1.02
Possible relation of osteopontin to development of psammoma bodies in human papillary thyroid cancer. Arch Pathol Lab Med (1998) 0.92
B-flow evaluation of carotid arterial stenosis: initial experience. Radiology (2002) 0.81
Thyroid ultrasonography as a screening tool for thyroid disease. Thyroid (2004) 0.81
Expression of osteopontin messenger RNA by macrophages in ovarian serous papillary cystadenocarcinoma: a possible association with calcification of psammoma bodies. Pathol Int (2000) 0.79
Combined use of color duplex ultrasonography and B-flow imaging for evaluation of patients with carotid artery stenosis. AJNR Am J Neuroradiol (2004) 0.78
Psammoma body and its precursors in papillary thyroid carcinoma: a study by fine-needle aspiration cytology. Diagn Cytopathol (2004) 0.78
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors. Nutr Metab Cardiovasc Dis (2004) 0.78
Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med (2007) 6.58
Subclinical thyroid disease. Lancet (2012) 4.18
Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev (2004) 3.14
Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med (2002) 2.31
Advances in the treatment of prolactinomas. Endocr Rev (2006) 2.31
Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab (2002) 2.15
Endocrine disorders during the first year after autologous stem-cell transplant. Am J Med (2005) 2.14
Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med (2003) 2.09
Ultrasonographic diagnosis of midgut volvulus with malrotation in children. J Pediatr Gastroenterol Nutr (2014) 2.03
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab (2004) 2.01
Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. JACC Cardiovasc Interv (2011) 1.94
Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol (2003) 1.79
Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis (2009) 1.75
The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Clin Endocrinol (Oxf) (2007) 1.73
Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. Endocrine (2013) 1.72
Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res (2004) 1.67
Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences. Eur J Endocrinol (2007) 1.66
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial. Osteoporos Int (2005) 1.61
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol (2005) 1.59
Traffic pollutants affect fertility in men. Hum Reprod (2003) 1.56
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab (2009) 1.53
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.53
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab (2003) 1.52
Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. Am J Gastroenterol (2009) 1.46
Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy. Leuk Lymphoma (2011) 1.43
The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. J Clin Endocrinol Metab (2008) 1.41
Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. J Pediatr Gastroenterol Nutr (2011) 1.41
Cushing's Syndrome. Endocrinol Metab Clin North Am (2008) 1.33
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab (2005) 1.32
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 1.31
Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study. Endocrine (2011) 1.29
Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol (Oxf) (2004) 1.29
Pathophysiology of diabetes mellitus in Cushing's syndrome. Neuroendocrinology (2010) 1.28
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. J Bone Miner Res (2004) 1.27
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA (2010) 1.22
Thyroid and obesity: an intriguing relationship. J Clin Endocrinol Metab (2010) 1.21
Foregut duplication of the stomach diagnosed by endoscopic ultrasound guided fine-needle aspiration cytology: case report and literature review. World J Surg Oncol (2013) 1.21
Resistance to somatostatin analogs in acromegaly. Endocr Rev (2010) 1.20
Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance. J Clin Endocrinol Metab (2006) 1.20
Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2006) 1.20
Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid (2009) 1.16
HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res (2009) 1.16
Prolactin and autoimmunity. Pituitary (2005) 1.15
The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin. Thyroid (2013) 1.15
Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer (2008) 1.13
Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline. J Clin Endocrinol Metab (2008) 1.13
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab (2005) 1.13
Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab (2004) 1.12
The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin North Am (2005) 1.12
Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. Cancer (2003) 1.11
Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review. BMC Surg (2013) 1.10
Can neonatal lung ultrasound monitor fluid clearance and predict the need of respiratory support? Crit Care (2012) 1.10
Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. J Am Soc Echocardiogr (2010) 1.09
Dopamine receptor expression and function in corticotroph pituitary tumors. J Clin Endocrinol Metab (2004) 1.08
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer (2002) 1.08
Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome. Eur J Endocrinol (2008) 1.07
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 1.07
Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report. Hum Reprod (2008) 1.07
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol (2002) 1.06
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients. J Clin Endocrinol Metab (2006) 1.06
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study. Clin Endocrinol (Oxf) (2003) 1.06
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. Eur J Endocrinol (2006) 1.05
Antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2006) 1.05
Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy. Clin Endocrinol (Oxf) (2007) 1.05
Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors. Ann Surg (2007) 1.05
Retracted Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: a pilot study for clinical and biochemical outcome of neoangiogenesis. BMC Surg (2012) 1.04
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. Eur J Endocrinol (2010) 1.04
Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells. J Mol Endocrinol (2008) 1.03
Subclinical hypothyroidism and cardiovascular risk: a reason to treat? Treat Endocrinol (2004) 1.03
The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy. Endocrinology (2006) 1.02
Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab (2002) 1.02
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 1.02
A new marker for diagnosis of thyroid papillary cancer: B-flow twinkling sign. J Ultrasound Med (2008) 1.02
Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy. J Clin Endocrinol Metab (2004) 1.01
Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegaly. Clin Endocrinol (Oxf) (2008) 1.00
Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity? Eur J Endocrinol (2008) 1.00
Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol (2008) 1.00
Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol (2003) 1.00
Measurement of spleen volume by ultrasound scanning in patients with thrombocytosis: a prospective study. Blood (2002) 1.00
Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol (2005) 0.99
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod (2007) 0.99
Novel insights in dopamine receptor physiology. Eur J Endocrinol (2007) 0.99
Cyclin D1 and D3 overexpression predicts malignant behavior in thyroid fine-needle aspirates suspicious for Hurthle cell neoplasms. Cancer (2009) 0.99
Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin Endocrinol (Oxf) (2006) 0.99
Grey-scale analysis allows a quantitative evaluation of thyroid echogenicity in the patients with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) (2003) 0.98